Top

Journal of Translational Medicine

Published in:

Open Access 01-12-2024 | Alkaloids | Letter to the Editor

A strategy to pioneer key agent(s) in Cephalotaxus alkaloids against pan-cancer via filtering methodology based on integrated pharmacology

Authors: Ki-Kwang Oh, Sang-Jun Yoon, Jung-A Eom, Kyeong Jin Lee, Goo-Hyun Kwon, Dong Joon Kim, Ki-Tae Suk

Published in: Journal of Translational Medicine | Issue 1/2024

Excerpt

Dear Editor, …

Available only for authorised users

Dixit P, Singh N, Singh L, Srivastava RP, Pandey S, Singh S, et al. Screening for the biochemical profile and biological activity in Cephalotaxus and Taxus collected from north-eastern Himalayas. ACS Agric Sci Technol Am Chem Soc. 2023;3:694–700. https://doi.org/10.1021/acsagscitech.3c00126.CrossRef

Xiao X, Wang W, Li Y, Yang D, Li X, Shen C, et al. HSP90AA1-mediated autophagy promotes drug resistance in osteosarcoma. J Exp Clin Cancer Res. 2018;37:1–13. https://doi.org/10.1186/s13046-018-0880-6.CrossRef

Oh K, Yoon S, Lee S, Lee SY, Gupta H, Ganesan R, et al. The juxtaposition of Ilex cornuta fruit and gut microbiota against alcoholic liver disease based on the integrated pharmacology via metabolomics. Clin Transl Med. 2023. https://doi.org/10.1002/ctm2.1392.CrossRefPubMedPubMedCentral

Shityakov S, Förster C. In silico predictive model to determine vector-mediated transport properties for the blood-brain barrier choline transporter. Advances and applications in bioinformatics and chemistry: AABC. Adv Appl Bioinform Chem. 2014;7:23–36.PubMedPubMedCentral

Title: A strategy to pioneer key agent(s) in Cephalotaxus alkaloids against pan-cancer via filtering methodology based on integrated pharmacology
Authors: Ki-Kwang Oh
Sang-Jun Yoon
Jung-A Eom
Kyeong Jin Lee
Goo-Hyun Kwon
Dong Joon Kim
Ki-Tae Suk
Publication date: 01-12-2024
Publisher: BioMed Central
Keywords: Alkaloids
Alkaloids
Published in: Journal of Translational Medicine / Issue 1/2024
Electronic ISSN: 1479-5876
DOI: https://doi.org/10.1186/s12967-024-05059-0

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2024

Metabolic heterogeneity in clear cell renal cell carcinoma revealed by single-cell RNA sequencing and spatial transcriptomics

Transcript and protein signatures derived from shared molecular interactions across cancers are associated with mortality

Redox proteomics of PANC-1 cells reveals the significance of HIF-1 signaling protein oxidation in pancreatic ductal adenocarcinoma pathogenesis

A PCR-independent approach for mtDNA enrichment and next-generation sequencing: comprehensive evaluation and clinical application

Targeting the SphK1/S1P/PFKFB3 axis suppresses hepatocellular carcinoma progression by disrupting glycolytic energy supply that drives tumor angiogenesis

A novel sub-regional radiomics model to predict immunotherapy response in non-small cell lung carcinoma

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials